SLC35A2‐CDG: Functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported Individuals
Authors:
Open Access
- 28 February 2019
- journal article
- research article
- Published by Wiley in Human Mutation
- Vol. 40 (7) , 908-925
Abstract
Pathogenic de novo variants in the X‐linked gene SLC35A2 encoding the major Golgi‐localized UDP‐galactose transporter required for proper protein and lipid glycosylation cause a rare type of congenital disorder of glycosylation known as SLC35A2‐congenital disorders of glycosylation (CDG; formerly CDG‐IIm). To date, 29 unique de novo variants from 32 unrelated individuals have been described in the literature. The majority of affected individuals are primarily characterized by varying degrees of neurological impairments with or without skeletal abnormalities. Surprisingly, most affected individuals do not show abnormalities in serum transferrin N‐glycosylation, a common biomarker for most types of CDG. Here we present data characterizing 30 individuals and add 26 new variants, the single largest study involving SLC35A2‐CDG. The great majority of these individuals had normal transferrin glycosylation. In addition, expanding the molecular and clinical spectrum of this rare disorder, we developed a robust and reliable biochemical assay to assess SLC35A2‐dependent UDP‐galactose transport activity in primary fibroblasts. Finally, we show that transport activity is directly correlated to the ratio of wild‐type to mutant alleles in fibroblasts from affected individuals.Keywords
Funding Information
- National Institutes of Health (R01DK099551)
This publication has 51 references indexed in Scilit:
- Neurology of inherited glycosylation disordersThe Lancet Neurology, 2012
- Comparative analysis of involvement of UGT1 and UGT2 splice variants of UDP-galactose transporter in glycosylation of macromolecules in MDCK and CHO cell linesGlycoconjugate Journal, 2011
- The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Characterization of a mutation and an alternative splicing of UDP-galactose transporter in MDCK-RCAr cell lineBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2006
- Point Mutations Identified in Lec8 Chinese Hamster Ovary Glycosylation Mutants That Inactivate Both the UDP-galactose and CMP-sialic Acid TransportersJournal of Biological Chemistry, 2001
- Transport of UDP-Galactose into the Golgi Lumen Regulates the Biosynthesis of ProteoglycansJournal of Biological Chemistry, 1996
- A new approach to mapping co-localization of multiple glycosyl transferases in functional Golgi preparationsGlycobiology, 1996
- Human melanoma and Chinese hamster ovary cells galactosylate n-alkyl-β-glucosides using UDP gal:GlcNAc β1,4 galactosyltransferaseGlycobiology, 1996
- The UDP-galactose translocator gene is mapped to band Xp11.23-p11.22 containing the Wiskott-Aldrich syndrome locusSomatic Cell and Molecular Genetics, 1993
- Translocation across golgi vesicle membranes: A CHO glycosylation mutant deficient in CMP-sialic acid transportCell, 1984